Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the U.S. Food and Drug ...

U.S. FDA Approves HYRNUO® (sevabertinib) for Previously Treated Patients with HER2-Mutated Locally Advanced or Metastatic Non-Squamous NSCLC ...

Shanghai Henlius Biotech, Inc. (2696.HK) announced that its self-developed innovative anti-PD-1 monoclonal antibody HANSIZHUANG (serplulimab, Hetronifly® in Europe), in combination with chemotherapy ...

This study presents a case report on pain management and comfort care practices for a 52-year-old male patient with advanced osteosarcoma recurrence and systemic metastasis. The patient presented with ...

Frank Penedo, Ph.D., Director of the new Survivorship and Supportive Care Institute at Sylvester Comprehensive Cancer Center, ...

SOTERIA Precision Medicine Foundation and CureMatch, Inc. today announced an expanded collaboration to deliver personalized, data-driven cancer treatment insights to members of the U.S. Special ...

For many people with cancer and other serious diseases, palliative care is an important element of their journey.